In the present study, we provide multiple lines of evidence supporting MEN1 as an important modulator of the AS process, the most important of which is that the deletion of MEN1 leads to aberrant AS profiles in mouse lung tissue, human lung cancer cells and human breast cancer cells (data not shown). This evidence concerns the gene MEN1 and breast carcinoma.